Information Journal Paper
APA:
Copy. (2019). HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer. Pathology Research and Practice, 215(5), 910-917. SID. https://sid.ir/paper/667937/en
Vancouver:
Copy. HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer. Pathology Research and Practice[Internet]. 2019;215(5):910-917. Available from: https://sid.ir/paper/667937/en
IEEE:
Copy, “HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer,” Pathology Research and Practice, vol. 215, no. 5, pp. 910–917, 2019, [Online]. Available: https://sid.ir/paper/667937/en